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Abstract
Background: Transcription factors play a key role in lineage commitment and differentiation of stem cells into distinct
mature cells. In hematopoiesis, they regulate lineage-specific gene expression in a stage-specific manner through various
physical and functional interactions with regulatory proteins that are simultanously recruited and activated to ensure timely
gene expression. The transcription factor CCAAT/enhancer binding protein a (C/EBPa) is such a factor and is essential for the
development of granulocytic/monocytic cells. The activity of C/EBPa is regulated on several levels including gene
expression, alternative translation, protein interactions and posttranslational modifications, such as phosphorylation. In
particular, the phosphorylation of serine 248 of the transactivation domain has been shown to be of crucial importance for
granulocytic differentiation of 32Dcl3 cells in vitro.
Methodology/Principal Findings: Here, we use mouse genetics to investigate the significance of C/EBPa serine 248 in vivo
through the construction and analysis of Cebpa
S248A/S248A knock-in mice. Surprisingly, 8-week old Cebpa
S248A/S248A mice
display normal steady-state hematopoiesis including unaltered development of mature myeloid cells. However, over time
some of the animals develop a hematopoietic disorder with accumulation of multipotent, megakaryocytic and erythroid
progenitor cells and a mild impairment of differentiation along the granulocytic-monocytic lineage. Furthermore, BM cells
from Cebpa
S248A/S248A animals display a competitive advantage compared to wild type cells in a transplantation assay.
Conclusions/Significance: Taken together, our data shows that the substitution of C/EBPa serine 248 to alanine favors the
selection of the megakaryocytic/erythroid lineage over the monocytic/granulocytic compartment in old mice and suggests
that S248 phosphorylation may be required to maintain proper hematopoietic homeostasis in response to changes in the
wiring of cellular signalling networks. More broadly, the marked differences between the phenotype of the S248A variant in
vivo and in vitro highlight the need to exert caution when extending in vitro phenotypes to the more appropriate in vivo
context.
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Introduction
The human body contains trillions of blood cells that are
continuously replaced through normal cell turnover. Hematopoi-
esis is the highly orchestrated process responsible for regulating the
generation of mature blood cells from a rare population of
hematopoietic stem cells (HSC). The HSCs possess the ability to
self-renew and differentiate into all blood lineages and are the
ultimate reservoir for maintaining the supply of blood cells
throughout life. Multiple mechanisms are required in order to
meet both the changing demands from the body and to maintain
steady-state hematopoiesis [1]. In particular, many transcription
factors have been shown to modulate key events in differentiation
and proliferation and their function in hematopoiesis has been
investigated thoroughly through the examination of knockout mice
[2]. One of these transcription factors is CCAAT/enhancer
binding protein alpha (C/EBPa), which is not only involved in
regulation of hematopoiesis, but also exerts its function in other
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38841tissues such as lung, liver and adipose tissue through the induction
of lineage-specific gene programs in combination with an ability to
promote cell cycle exit [3,4,5]. Within the hematopoietic system,
C/EBPa has been shown to be important for the myeloid lineage,
since conditional deletion of the Cebpa allele in the hematopoietic
compartment of adult mice blocks the transition from common
myeloid progenitors (CMPs) to granulocyte-monocyte progenitors
(GMPs), thus resulting in complete loss of granulocytes, monocytes
and eosinophils [6,7]. Besides this late granulocytic-monocytic
differentiation block, fetal livers of newborn Cebpa null mice display
increased numbers of progenitors and mature cells of the erythroid
lineage, suggesting that C/EBPa might play a role in repressing
erythroid differentiation [7]. In line with this, overexpression of C/
EBPa in erythroid progenitor cells, redirects the differentiation
potential in a granulocytic direction resulting in an increased level
of mature granulocytes and granulocyte-monocyte progenitors
with a concomitant decrease of erythroid progenitors [8].
The activity of C/EBPa is tightly controlled through multiple
layers of regulation. First of all, timely expression is required and
involves regulation of gene transcription, mRNA translation and
protein degradation [9,10]. Secondly, protein interactions have a
major impact on the ability of C/EBPa to induce or repress gene
transcription [11,12,13]. Thirdly, C/EBPa activity can be altered
by posttranslational modifications such as sumyolation and
phosphorylation [14,15]. The phosphorylation status of serine 21
(S21) has been shown to have a major impact on the decision to
differentiate towards the monocytic or granulocytic lineage in vitro.
Upon phosphorylation of S21 or expression of a phospho-
mimicking mutant in K-562 cells, granulopoiesis is inhibited,
thereby favoring monocytic differentiation at the cost of granu-
locytic differentiation [15,16]. Furthermore, the phosphorylation
of serine 248 in the transactivation domain has been suggested to
be required for myeloid differentiation since mutating it to an
alanine residue abrogates the capacity of C/EBPa to induce
granulocytic differentiation of 32Dcl3 cells in vitro [17]. Serine 248
(S248) is phosphorylated by activated Ras signaling and this
phosphorylation increases the ability of C/EBPa to promote
expression from the G-CSF receptor promoter. Therefore, it
appears that phosphorylation and dephosphorylation of C/EBPa
at distinct serine residues can directly push the cells towards a
specific myeloid branch. However, these phosphorylation sites
have only been investigated in an in vitro context and what the
functions are in vivo is therefore unknown.
We and others have previously reported on several Cebpa knock-
in mouse models [18,19,20,21,22,23], which have provided
valuable information pertaining the role of C/EBPa in myeloid
differentiation and in the development of leukemia. In this study,
we use knock-in mutagenesis to elucidate the importance of S248
phosphorylation for myeloid differentiation by introducing an
allele of Cebpa with an alanine substituted for serine 248, thereby
abrogating phosphorylation of this residue. Surprisingly, we could
show that whereas myeloid differentiation of cells expressing C/
EBPa-S248A is blocked in vitro, this is not the case in vivo. Thus,
young Cebpa
S248A/S248A mice display no phenotypic alterations in
the hematopoietic compartment or other tissues. In contrast, aged
Cebpa
S248A/S248A animals develop a low-penetrant myeloid disor-
der characterized by a mild impairment of differentiation along
the granulocytic-monocytic lineage and by the accumulation of
HSCs, multipotent progenitor cells (MPPs), as well as megakar-
yocytic and early erythroid progenitors.
Results
S248 is required for C/EBPa to promote granulocytic
differentiation in vitro
The murine myeloid 32Dcl3 cell line has long been considered a
suitable in vitro model system for analyzing myelopoiesis, since it is
one of the few cell lines that can terminally differentiate into
mature neutrophils. The cell line is diploid and non-leukemic in
syngenic murine recipients [24,25]. It proliferates in media
containing IL-3 however, upon removal of this cytokine and
addition of G-CSF, proliferation ceases and differentiation into
neutrophil granulocytes proceeds. It is well documented that
ectopic expression of C/EBPa in 32Dcl3 cells is sufficient to
induce terminal granulocytic differentiation even in the presence
of IL-3, making this a suitable differentiation assay to analyze the
effect of C/EBPa mutations on this process [24,25]. In order to
investigate if C/EBPa-S248A is defective in granulocytic-mono-
cytic in vitro differentiation as previously reported [17], 32Dcl3
clones expressing either a wild type C/EBPa-estrogen receptor
ligand-binding domain fusion protein (C/EBPa-ER) or the C/
EBPa-S248A-ER variant were constructed and clones expressing
an equal amount of protein were selected for further analysis
(Figure 1A).
To test whether S248 is required for the ability of C/EBPa to
promote granulocytic differentiation C/EBPa-ER was translocat-
ed to the nucleus by addition of 4-hydroxytamoxifen (4-OHT).
Cells were monitored for three days, and samples were collected
each day and analyzed by flow cytometry to assess proliferation
(Figure 1D) and granulocytic differentiation (Figure 1B, C). As
expected 32Dcl3-C/EBPa-ER cells exited cell cycle within a few
days, the G1/S ratio increased 15 fold (Figure 1D) and cells
became positive for the granulocytic-monocytic marker Mac-1 and
later for Gr-1 (Figure 1B, C). On the other hand, nuclear
translocation of C/EBPa-S248A-ER did not lead to growth arrest
and cells failed to express the two differentiation markers.
Thus in agreement with previous findings [17], these data show
that S248 is necessary for C/EBPa to induce growth arrest and
differentiation of neutrophil granulocytes in vitro.
Initial analysis of Cebpa
S248A/S248A knock-in mice
In order to investigate the importance of C/EBPa-S248 in vivo,
we generated a knock-in mouse line, in which the wild type Cebpa
gene was replaced with an allele expressing C/EBPa-S248A.
Cebpa
S248A/S248A knock-in mice were born and weaned in
Mendelian ratios, were physically indistinguishable from both
wild type littermates and the more appropriate Cebpa
KI/KI controls
[20,26], showed no visible signs of illness and were fully fertile
(data not shown), thus demonstrating that S248 of C/EBPa is fully
dispensable for embryonic survival. Furthermore, inspection of
tissues in which C/EBPa function has previously been demon-
strated to be important, such as liver, lung, spleen and white
adipose tissue revealed no obvious abnormalities neither in terms
of morphology nor size in the Cebpa
S248A/S248A animals (Figure S1
and data not shown). These findings suggest that S248 is
dispensable for the development and maintenance of these tissues.
Young Cebpa
S248A/S248A mice are phenotypically normal
in the hematopoietic system
C/EBPa is a key regulator of myeloid differentiation and
altered C/EBPa activity has been shown to affect hematopoietic
development and predispose to myeloid malignancies such as
AML [3,21,22]. Moreover, the finding that C/EBPa-S248A was
unable to direct granulocytic-monocytic differentiation in vitro
prompted us to investigate the hematopoietic system of Ceb-
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S248A/S248A mice. Bone marrows (BM) from 8 week-old
Cebpa
S248A/S248A and Cebpa
KI/KI mice were collected and stained
with antibodies for cell-surface markers specific for the different
mature lineages and analyzed by flow cytometry. Surprisingly, in
contrast to the in vitro data reported above, mutation of S248 did
not alter the frequency of mature granulocytes (Mac-1+, Gr-1+)
and the prevalence of other BM populations such as B cells
(B220+), T cells (CD4+ and/or CD8+), erythroid cells (Ter119+,
CD71+/int) was also unaffected (Figure 2A, B). Furthermore,
examination of cytospins prepared from BM or spleen from 8
week-old mice showed no aberrations in cellular morphologies or
distributions (Figure 2C, D). These data suggest, that S248 of C/
EBPa is dispensable for the in vivo development of mature
hematopoietic lineages.
Since Cebpa null mice have previously been shown to accumulate
myeloid progenitors and to harbor a differentiation block
upstream of the GMP [6], we analyzed the myeloid progenitor
compartment using the antibody panel reported by Pronk et al.
[27]. However, we were unable to detect any major alterations in
the cellular distributions of myeloid progenitors or HSCs/MPPs
(Figure 3A, B), suggesting that S248 of C/EBPa is not required for
steady state lineage commitment or differentiation of myeloid
progenitors in young mice.
To evaluate the myeloid progenitors functionally, we next
plated BM cells from 8 week-old Cebpa
S248A/S248A and Cebpa
KI/KI
animals in semisolid media to allow for the outgrowth of all
myeloid colonies. In contrast to previous studies involving BM
progenitors derived from other Cebpa mutant mouse lines [19,21],
Cebpa
S248A/S248A BMs yielded similar distributions of BFU-E,
CFU-GM and CFU-GEMM colonies as the Cebpa
KI/KI controls
(Figure 3C). Furthermore, when we analyzed the proliferative
consequences of mutating S248 by performing serial replating of
colonies derived from the first round of plating, Cebpa
S248A/S248A
progenitors displayed the same limited proliferative potential as
progenitors from the Cebpa
KI/KI controls when counted either as
colonies (Figure 3D) or as total cell number (data not shown).
In conclusion, at eight weeks of age Cebpa
S248A/S248A mice
display no overt phenotype in the hematopoietic compartment.
A fraction of Cebpa
S248A/S248A mice develop a low-
penetrant hematopoietic disorder with long latency
Many hematopoietic diseases are particularly prevalent in the
elderly population, but the mechanisms involved are not resolved
but may be related to an increase in myeloid-based HSCs upon
ageing or accumulation of acquired genetic mutations [28]. We
therefore analyzed a cohort of Cebpa
S248A/S248A animals at one
year of age (12–14 months) to detect whether mutation of S248 led
to any phenotypic changes in the hematopoietic compartment in
older animals. At this age, several of the Cebpa
S248A/S248A mice (4/
Figure 1. C/EBPa-S248A cannot induce differentiation of 32Dcl3 cells. (A) Western blot analysis of 32Dcl3 clones expressing C/EBPa-ER (wt)
or C/EBPa-S248A-ER (S248A). (B) Flow cytometry analysis of expression of the granulocytic-monocytic markers Mac-1 and Gr-1 following 4-OHT
addition to the C/EBPa-ER or C/EBPa-S248A-ER expressing clones. (C) Quantification of the flow cytometry data in (B) from two experiments using
two independent wt-ER and S248A-ER clones (mean +/2 standard deviation). (D) Quantification of the G1/S ratios determined by flow cytometry of
BrdU and Propidium Iodide stained cell cultures. The data is from two experiments (mean +/2 standard deviation).
doi:10.1371/journal.pone.0038841.g001
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wild type controls were phenotypically indistinguishable from the
young wild type controls.
Next, we analyzed the distribution of the mature hematopoietic
populations within the BM of cohorts of Cebpa
KI/KI control and
Cebpa
S248A/S248A mice. In the BM from Cebpa
S248A/S248A mice
there was a slight reduction in mature neutrophil granulocytes
(Mac-1+, Gr-1+) and a concomitant increase in erythroid
progenitors (Ter119+, CD71+), whereas the lymphoid compart-
ment was unaffected compared to the Cebpa
KI/KI controls
(Figure 4A, B).
To further delineate this apparent skewing towards the
erythroid lineage and to test whether this was driven by a few
Cebpa
S248A/S248A individuals or the entire cohort, we analyzed the
myeloid progenitor compartment (Figure 5A). In contrast to young
mice, a subset of the one year-old Cebpa
S248A/S248A animals
displayed reduced levels of GMPs accompanied by an increase in
preMegEs. Whereas 6% (1 out of 17) Cebpa
KI/KI mice had a
Figure 2. Young Cebpa
S248A/S248A mice display no overt hematopoietic phenotype. (A) The mature hematopoietic lineages in the BM from
8 week-old Cebpa
KI/KI and Cebpa
S248A/S248A mice were analyzed by flow cytometry using cell surface-specific markers for neutrophil granulocytes
(M=Mac-1+, Gr-1+), erythroid cells (E=CD71+, Ter119+), B cells (B=B220+) and T cells (T=CD4+ or CD8a+). (B) Quantification of the data from (A).
Cebpa
KI/KI (n=6) and Cebpa
S248A/S248A (n=6) (mean +/2 standard deviation). (C) Cytospin analysis of BM and spleen cells from Cebpa
+/+ and
Cebpa
S248A/S248A mice. (D) Differential counts of the cytospins in (C) from Cebpa
+/+ (n=3) and Cebpa
S248A/S248A (n=4) (mean +/2 standard deviation).
Abbreviations indicate the granulocytic (Myeloblasts (MB); Promyelocytes (PM); Myelocytes (My); Metamyelocytes (MM); Band cells (Band) and
Polymorphonuclear Granulocytes (PMN)) monocytic (Promonocytes (Pmo); Monocytes (Mo)), erythroid (Proerythrocytes (Pery); Erythrocytes (ery);
basophilic normoblast (bNB); polychromatic normoblast (pNB)); lymphocytes (Ly); eosinophils (Eo) and plasma cell (PC) types.
doi:10.1371/journal.pone.0038841.g002
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the Cebpa
S248A/S248A animals displayed a GMP/preMegE ratio
lower than the mean of the Cebpa
KI/KI animals minus one standard
deviation (Figure 5B and Figure S2). These phenotypically
progressed Cebpa
S248A/S248A mice had a significant increase in
the preGMs (Figure 5C), indicating partially impaired differenti-
ation towards the granulocyte-monocytic compartment at the
preGM to GMP transition, where C/EBPa executes its lineage-
instructive function [6,7].
Furthermore, the partly impaired preGM to GMP transition
was accompanied by increased levels of megakaryocytic and
erythroid progenitors (preMegE, MkP, preCFU-E), suggesting that
Figure 3. Young Cebpa
S248A/S248A mice show no abnormalities in the hematopoietic stem and progenitor compartment. (A) Flow
cytometry analysis of the stem and progenitor compartment in the BM from Cebpa
KI/KI and Cebpa
S248A/S248A. (B) Quantification of the data in (A).
There were no significant changes in Cebpa
KI/KI (n=6) and Cebpa
S248A/S248A (n=6) mice (mean +/2 standard deviation). (C) Colony forming unit
assays of BM cells from Cebpa
KI/KI (n=4) and Cebpa
S248A/S248A (n=4) mice (mean +/2 standard deviation). (D) Serial replating of the primary colonies
from (C) showing the behavior of 3 individual mice of each genotype.
doi:10.1371/journal.pone.0038841.g003
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the cells towards the erythroid lineage (Figure 5C). This lineage-
skewing was also detected in colony assays, where Cebpa
S248A/S248A
BM gave rise to significantly more BFU-Es than the Cebpa
KIKI
control (Figure 4C).
In addition to the observed changes in the committed
progenitor compartments, a fraction of the one year-old
Cebpa
S248A/S248A animals with biased lineage choice displayed
increased frequencies of the HSC/MPP-enriched Lineage nega-
tive, Sca-1+, c-Kit+ (LSK) population compared to Cebpa
KI/KI
mice. Further resolution of this compartment showed that the
progressed Cebpa
S248A/S248A BM had a two-fold expansion of
MPPs compared to Cebpa
KI/KI controls as well as a trend towards
increased numbers of HSCs (Figure 5C). Notably, we observed
only a partial overlap between delayed preGM to GMP transition
and expansion of the stem and multipotent progenitor compart-
ment (Figure S2), suggesting that these events occur by different
mechanisms.
Next we wanted to assess in more detail whether there existed
any correlations between the different aberrant phenotypes
(enlarged spleen, expanded LSK compartment, erythroid-biased
differentiation, etc) that we observed in old Cebpa
S248A/S248A
animals. We therefore subjected a second cohort of old animals
(18–24 months) to the full experimental regime and in support of
our initial findings, this group of Cebpa
S248A/S248A animals
displayed essentially the same phenotypic characteristics as the
previously analyzed 1-year old cohort: Thus, whereas all (8 out of
8) Cebpa
KI/KI mice had a phenotypical normal spleen, 29% (6 out
of 21) of the Cebpa
S248A/S248A animals displayed splenomegaly at
various degrees (Figure S3C). Twenty-nine % (6 out of 21) of the
Cebpa
S248A/S248A animals had an expansion of the LSK compart-
ment compared to 13% (1 out of 8) of Cebpa
KI/KI (Figure S3B).
Moreover, 29% (6 out of 21) of Cebpa
S248A/S248A mice had a
reduced GMP/preMegE ratio in the BM compared to 0% (0 out
of 8) of the Cebpa
KI/KI mice (Figure S3A). The phenotypes of the
older Cebpa
S248A/S248A mice are summarized in Table 1 and
Figure 6. Specifically when mice are binned according to GMP/
preMegE ratios, the fraction of Cebpa
S248A/S248A animals associ-
ated with decreased GMP/preMegE ratios are significantly
elevated compared to Cebpa
KI/KI controls.
Importantly, the full complement of analyses performed on the
18–24 month cohort allowed us to draw a number of correlations
between the different aberrant phenotypes in the old Cebpa
S248A/
S248A animals. Thus, whereas we detected a low partial overlap of
mice with decreased GMP/preMegE ratio and increased LSK
compartment, there was no detected correlation between mice
with enlarged spleen and reduced GMP/preMegE ratio. In
contrast, there was a considerable overlap of mice with expanded
LSK compartment and enlarged spleen (Figure S3D–G).
At this age the phenotypically progressed Cebpa
S248A/S248A mice
had slightly lower levels of mature monocytes/granulocytes in the
BM and an increased amount of mature erythroid cells in the BM
compared to Cebpa
KI/KI mice (Figure S4A). In line with this, BM
cells from the progressed Cebpa
S248A/S248A mice displayed signif-
icantly more BFU-E colonies in CFU assays, whereas the CFU-
GM and CFU-GEMM were unaltered compared to BM from
Cebpa
KI/KI mice (Figure S4B).
Taken together, a fraction of old mice defective in the
phosphorylation of S248 of C/EBPa exhibit a slowly developing
low penetrant hematopoietic disorder(s) associated with distur-
Figure 4. One-year old Cebpa
S248A/S248A mice display an erythroid lineage bias. (A) Flow cytometry analysis of mature populations in BMs
from Cebpa
KI/KI (n=6) and Cebpa
S248A/S248A (n=6) mice. Analyzed populations: Erythroid cells (E=CD71+, Ter119+), granulocytes (M=Mac-1+, Gr-1+);
B-cell (B=B220+) and T-cells (T=CD4+ or CD8a+). (B) Quantification of the data from (A). (C) Colony forming unit assays of BM cells from Cebpa
KI/KI
(n=4) and Cebpa
S248A/S248A (n=5) mice (mean +/2 standard deviation).
doi:10.1371/journal.pone.0038841.g004
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and MPPs.
The slowly developing hematopoietic disorders in old
Cebpa
S248A/S248A animals are cell-intrinsic
To investigate whether the above-described phenotypes are cell-
intrinsic to the hematopoietic compartment, we reconstituted
lethally irradiated recipients (CD45.1) with whole BM from 8
week-old Cebpa
S248A/S248A and Cebpa
KI/KI donors (CD45.2), and
analyzed recipient BM 16 weeks post-transplantation.
Similar to what was observed in one year-old Cebpa
S248A/S248A
mice, a fraction (4/7) of the recipients transplanted with
Cebpa
S248A/S248A BMs displayed diminished levels of GMPs and
accumulation of megakaryocytic and erythroid progenitors (pre-
MegE and pre-CFU-E) in comparison to recipient mice
transplanted with Cebpa
KI/KI control BM (Figure 7 and Figure
S5). Consistent with the phenotype in the Cebpa
S248A/S248A mice,
there was only a partial overlap between the disturbance in the
myeloid compartment and increased numbers of LSK cells (Figure
S5), which supports the notion that the partly halted granulocytic-
monocytic differentiation and the accumulation of HSCs and
MPPs occur by two distinct mechanisms.
To test whether the S248A allele results in a stem cell
repopulation advantage or disadvantage compared to the wild
type knock-in allele, we performed serial competitive BM
transplantations, in which whole BM (CD45.2) from eight week-
old Cebpa
S248A/S248A and Cebpa
KI/KI mice was mixed in a 1:1 ratio
with competitor BM (CD45.1) and transplanted into lethally
irradiated CD45.1 recipients. Recipient BM was harvested 18
weeks post-transplantation and donor (CD45.2) versus competitor
Figure 5. A fraction of the one-year old Cebpa
S248A/S248A mice develops a myeloid disorder with biased lineage choice. (A) Flow
cytometry analysis of the myeloerythroid progenitor compartment in BMs from Cebpa
KI/KI (n=17) and Cebpa
S248A/S248A (n=23) mice. (B) Seven out of
23 Cebpa
S248A/S248A mice (termed ‘‘progressed’’) had a skewed lineage distribution with a decreased GMP/preMegE ratio compared to Cebpa
KI/KI.
Black line indicates cut-off. Cut-off was defined as mean of Cebpa
KI/KI2standard deviation. (C) Quantification of the data from (A). Numbers of mice in
each of the groups were as follows: Cebpa
KI/KI (n=17), Cebpa
S248A/S248A (n=16) and progressed Cebpa
S248A/S248A (n=7) mice. P values designate
significance between progressed Cebpa
S248A/S248A and Cebpa
KI/KI, ns=not significant (mean +/2 standard deviation).
doi:10.1371/journal.pone.0038841.g005
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respectively. To test whether a repopulation phenotype could be
uncovered when further proliferative stress was applied to the
hematopoietic system, we transplanted pooled whole BM from 6–
7 primary recipients (Figure 8B) into secondary recipients, which
were analyzed 21 and 34 weeks post-transplantation. At 21 weeks
after secondary transplantation, the LSK compartment of mice
transplanted with Cebpa
S248A/S248A was significantly increased
compared to mice transplanted with Cebpa
KI/KI BM and this
increased contribution in the stem cell compartment of Cebpa
S248A/
S248A mice resulted in a significant increase of donor BM cells at 34
weeks post-transplantation (Figure 8C, D). It should be noted that
a selective advantage of donor- versus competitor cells was also
observed in mice transplanted with Cebpa
KI/KI secondary donors,
since the donor/competitor ratio had also increased relative to
input cells in these animals. Therefore, some selective advantage
must be assigned to the genetic background of the cells used.
However, the effect was significantly higher in the Cebpa
S248A/
S248A secondary recipients suggesting that the S248A mutation
confer a mild selective advantage to the HSC/MPP compartment.
In summary, the Cebpa S248A allele results in a low-penetrant
cell-intrinsic partly impairment of granulocytic-monocytic differ-
entiation accompanied by skewing towards the megakaryocytic
and erythroid compartment in a fraction of aged animals.
Furthermore, these data show that Cebpa
S248A/S248A HSCs have
a competitive advantage compared to their wild type counterparts




Protein phosphorylation represents an important layer of
cellular regulation, which may affect the stability, activity and
functional property of the modified protein. Whether phosphor-
ylation of key regulators plays a role in normal hematopoiesis has
only been addressed to a limited extent and mainly in a cell culture
context. The key hematopoietic regulator C/EBPa contains a
number of phosphorylation sites that confer regulation under a
variety of conditions [15,29,30]. Previously, Ras-dependent
phosphorylation of C/EBPa at S248 was reported to increase its
transactivational activity and promote increased granulocytic-
monocytic differentiation in vitro, whereas Erk-dependent phos-
phorylation of S21 inhibited the same process [15,17]. Further-
more, it has been shown that S21 must be dephosphorylated in
order to induce not only expression of granulocytic-monocytic
markers but also the erythroid-specific CD71 [16]. These findings
suggest that the phosphorylation status of C/EBPa is potentially
involved in regulating both granulopoiesis and erythropoiesis.
In order to extend this analysis to the proper in vivo context, we
decided to generate mice, in which the wild type Cebpa gene was
replaced by an allele containing a S248A substitution. Before
initiating the phenotypic analysis of these animals we verified the
previous reports on the requirement of S248 for in vitro
differentiation of granulocytic-monocytic cell lines [17,31]. Indeed,
by introducing C/EBPa-ER and C/EBPa-S248A-ER into 32Dcl3
cells, we could show that the S248A variant is unable to promote
myeloid differentiation. Whereas C/EBPa-ER induces the
expression of myeloid markers such as Mac-1 and Gr-1
accompanied by cell cycle exit, 32Dcl3 cells expressing C/
EBPa-S248A-ER fail to induce expression of these markers and
Figure 6. Distribution of mice based on GMP/preMegE ratio and LSK numbers. (A)Mice(age 1–2years old)were binnedbased ontheir GMP
to preMegE progenitor ratio (,mean of Cebpa
KI/KI2standard deviation; mean of Cebpa
KI/KI+/2standard deviation and .mean of Cebpa
KI/KI+standard
deviation), (P=0,012, Fishers exact test). (B) Mice (age 1–2 years old) were binned based on their level of LSK cells (,mean of Cebpa
KI/KI2standard
deviation; mean of Cebpa
KI/KI+/2standard deviation and .mean of Cebpa
KI/KI+standard deviation), (P=0,14, Fishers exact test). Total number of 1–2
year-old mice: Cebpa
KI/KI (n=25), Cebpa
S248A/S248A (n=44). See Table 1 for an overview of the phenotypes.
doi:10.1371/journal.pone.0038841.g006
Table 1. Overview of the phenotypes of Cebpa
S248A/S248A and Cebpa
KI/KI mice.
8 weeks 1 year 1,5–2 years
Genotype KI S248A KI S248A KI S248A
Low GMP/preMegE ratio 0/6 0/6 1/17 (6%) 7/23 (30%) 0/8 6/21 (29%)
Expanded LSK compartment 0/6 0/6 2/17 (12%) 7/23 (30%) 1/8 (13%) 6/21 (29%)
Enlarged spleen 0/6 0/6 0/17 4/23 (17%) 0/8 6/21 (29%)
doi:10.1371/journal.pone.0038841.t001
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is required in order for the cells to differentiate into mature
granulocytic-monocytic cells in vitro.
Given the strong requirement for S248 for in vitro granulocytic-
monocytic differentiation, we were surprised to find that young
Cebpa
S248A/S248A mice and their relevant controls contain a similar
number of mature and immature myeloid cells. In line with this,
BM cells plated in semi-solid media result in outgrowth of an equal
amount of colonies with similar distributions of myeloid progen-
itors from Cebpa
S248A/S248A and Cebpa
KI/KI mice. This suggests
that in young mice, S248 is dispensable for the induction of
granulocytic-monocytic differentiation, and consequently, that
phosphorylation of S248 is neither required for the preGM to
GMP transition nor for the differentiation into mature neutrophil
granulocytes in mice at 8 weeks of age.
Interestingly, a fraction of older Cebpa
S248A/S248A mice develop a
myeloid disorder in which differentiation towards the megakaryo-
cytic and erythroid lineage is promoted at the expense of
granulocytic-monocytic differentiation as evident by an increase
in early megakaryocytic and erythroid progenitors and a
corresponding decrease in their granulocytic-monocytic equiva-
lents. Another, partly overlapping, fraction of older Cebpa
S248A/
S248A mice presents with a mild expansion of the HSC-containing
LSK compartment.
Collectively, these data contribute to the increasing body of
evidence pointing towards C/EBPa as an important regulator of
cell fate decisions in progenitors more primitive than GMPs.
Conditional Cebpa knockout in the hematopoietic system in adult
mice blocks the transition from CMP to GMP resulting in loss of
granulocytes and monocytes but increases the numbers of myeloid
Figure 7. The phenotype in Cebpa
S248A/S248A is cell-intrinsic. (A) Flow cytomtery analysis of recipients transplanted with BM from Cebpa
KI/KI
(n=7) and Cebpa
S248A/S248A (n=7) mice. (B) Quantification of data from (A). Four out of seven of the Cebpa
S248A/S248A transplanted mice displayed a
reduced GMP to preMegE ratio (as defined in Figure S5) and was termed progressed. Numbers of mice in the other groups of transplanted mice were
as follows: Cebpa
KI/KI (n=7) and Cebpa
S248A/S248A (n=3) mice. P values designate significance between progressed Cebpa
S248A/S248A and Cebpa
KI/KI,
ns=not significant (mean +/2 standard deviation).
doi:10.1371/journal.pone.0038841.g007
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2/2 fetal liver contains
increased numbers of erythroid progenitors and erythroid cells
[32]. Furthermore, ectopic expression of C/EBPa in HSCs
induces granulocyte-monocytic differentiation and inhibits ery-
throid development resulting in an increase in mature granulo-
cytes and loss of megakaryocytic and erythroid progenitors [33]. In
line with this, mice with mutations in the Cebpa allele that either
reduce the transcriptional activity of the protein or destroy its
growth inhibitory function, all lack mature neutrophil granulocytes
and have increased numbers of erythroid cells [19,20,21,23].
However, as these mice age, they progress from the neutropenic
phenotype to a myeloid proliferative condition and later to an
AML-like disease, showing first of all, that mutations in Cebpa
result in a predisposition to myeloid diseases. Similarly, expression
of the C/EBPa-S248A variant might act as an initiating factor in a
multi-hit myeloid disorder associated with a biased lineage choice.
As the development of this disorder might require additional
genetic lesions this model also explains why only a fraction of the
aged Cebpa
S248A/S248A mice develop disease whereas others appear
normal.
Growing evidence suggests that tight regulation of lineage-
specific transcription factors plays a major role in the HSC
compartment. In accordance, it has been shown that mice with
various mutations in Cebpa have deregulated stem cell pools
[19,20,21,23]. The data presented in this work also support a
functional role for C/EBPa in HSCs since a fraction of the 1–2
years old Cebpa
S248A/S248A mice present with an expanded LSK
compartment. Furthermore, upon serial whole BM transplanta-
tion we observed a competitive advantage of Cebpa
S248A/S248A BM
cells compared to Cebpa
KI/KI controls and after the second round
of transplantation the Cebpa
S248A/S248A BM cells have overtaken
the recipient BM. Formally, we cannot exclude the possibility that
the donor-derived cells in one or more of the primary recipients
had an expansion of the LSK compartment. Therefore it is
unclear whether the observed increased selective advantage of
Cebpa
S248A/S248A BM cells is due to an acquired event leading to an
increase of functional stem cells or an increase of self-renewal per se
in older Cebpa
S248A/S248A HSCs. In either case, our data
demonstrates that the S248A mutation confers a competitive
advantage to HSCs, when these are subjected to proliferative
stress.
The development of hematopoietic disorders in older Ceb-
pa
S248A/S248A animals may in principle be explained by two non-
exclusive models: One formal possibility is that C/EBPa-S248 is
receiving input from a signalling transduction pathway that
changes its activity in an age-dependent manner. Precedence for
such a model comes from studies of rodent livers, where C/EBPa
display different phosphorylation patterns in young and old
animals. Specifically, the proportion of C/EBPa that is phosphor-
ylated on S193 by cyclin D3-cdk4/6 increase with age, which
correlates with the expression pattern of cyclin D3, and results in a
reduced ability to eliminate the growth repressive potential of C/
EBPa through dephosphorylation of S193 after partial hepatec-
tomy [34,35,36].
Alternatively, the hematopoietic disorders in the old Cebpa
S248A/
S248A animals arise as a result of different additional genetic/
epigenetic events in the Cebpa
S248A/S248A mice, which facilitate the
progression into an erythroid-biased condition, the expansion of
the LSK compartment or both. We favour this second model as
the Cebpa
S248A/S248A mice with an expanded LSK compartment
and an erythroid-biased lineage choice only partially overlap,
which suggests that these phenotypes are driven by distinct
Figure 8. Cebpa
S248A/S248A BM cells have a competitive advantage in comparison to Cebpa
KI/KI BM cells. (A) Whole BM from Cebpa
KI/KI
and Cebpa
S248A/S248A mice (CD45.2) was mixed in a 1:1 ratio with whole competitor BM (CD45.1) and transplanted into lethally irradiated mice. BM
donor contribution was assessed 18 weeks post-transplantation. Cebpa
KI/KI (n=7) and Cebpa
S248A/S248A (n=6) BM cells. (B) Input BM for the secondary
transplantation show similar levels of Cebpa
S248A/S248A and Cebpa
KI/KI contribution in the two input samples. (C, D) BM donor contribution in whole
BM (wBM) or in the LSK compartment of the secondary recipients was analyzed after 21 (C) and 34 (D) weeks. Cebpa
S248A/S248A transplanted mice
(n=4; black bars); Cebpa
KI/KI transplanted mice (n=4; white bars).
doi:10.1371/journal.pone.0038841.g008
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possibility that mutation of S248 makes hematopoietic cells more
susceptible to age-dependent changes in signal transduction
pathways operating through C/EBPa.
In conclusion, our data show that S248 is dispensable for
normal steady-state hematopoiesis, and that Cebpa
S248A/S248A mice
develop a low-penetrant myeloid disorder with age associated with
a mild skewing towards the erythroid lineage and a partial
differentiation block at the preGM to GMP transition. Addition-
ally, Cebpa
S248A/S248A BM display a competitive advantage during
serial transplantation suggesting that phosporylation of S248 may
normally serve to restrict HSC self-renewal in ageing mice.
In more general terms, the stark difference between the in vitro
and in vivo phenotypes of the S248A mutant highlights the need to
exert caution when extrapolating in vitro data to a more
appropriate in vivo setting. Moreover, the phenotypic progression
in old Cebpa
S248A/S248A mice to a condition with a partial
resemblance to the in vitro phenotype of mutating S248 may
suggest that granulocytic-monocytic cell lines could be wired in a
manner–either genetically or in terms of active signal transduction




All mouse work was performed according to national and
international guidelines and approved by the Danish Animal
Ethical Committee. This study was approved by the review board
at the Faculty of Health Sciences, University of Copenhagen (P10-
014).
Cell culture
All cell lines were grown at 37uCa t5 %C O 2. 32Dcl3 cells were
kindly provided by A. Friedmann [24,25]. The cells were grown in
IMDM with L-Glutamine and 25 mM Hepes (Gibco) supple-
mented with 10% FBS (HyClone), 100 mg/ml penicillin/strepto-
mycin (Gibco) and 1 ng/ml IL3 (Stem cell Technologies). For
culturing stable transfectants 1 mg/ml puromycin (Sigma) was
added. Differentiation of 32Dcl3 cells expressing ER
TM fusion
proteins was induced by addition of 4-hydroxytamoxifen (4-OHT,
Sigma) in the presence of IL3. Phoenix-E cells (obtained from
ATCC) were cultured in DMEM (Gibco) supplemented with 10%
FBS (HyClone) and 100 mg/ml penicillin/streptomycin (Gibco).
Generation of C/EBPa-expressing cells
A plasmid expressing rat C/EBPa was kindly provided by G.
Behre. pBabePuro- C/EBPa-S248A-ER
TM was constructed by
ligating a Sfi I/EcoRI fragment containing the S248A substitution
in place of the identical wild type fragment in pbabePuro-C/
EBPa-ER
TM.




containing supernatant was collected after two and three days.
32Dcl3 cells were infected and selected by addition of puromycin
as described in [18]. Cells were limited-diluted in 96-well culture
dishes to obtain clones, which were expanded and tested for
expression of C/EBPa or C/EBPa-S248A by western blotting.
Western Blotting
Western blotting was performed as previously described [18]
and probed with antibodies against C/EBPa (14AA, sc-61) and
Cdk2 (Sc-163) from Santa Cruz Biotechnology.
Cell cycle analysis
The cell cycle distribution was analyzed at day 0–3 after
addition of 4-OHT as previously described [18].
Mouse work and procedures
The Cebpa-S248A mutant was generated by using the
Quickchange mutagenesis kit (Stratagene) and confirmed by
sequencing. Cloning of the targeting construct, electroporation,
selection of E14.1 ES cells, blastocyst injection and breeding of
chimera was performed as described previously [20]. The
Cebpa
S248A and Cebpa
KI alleles were backcrossed to C57BL/6 for
at least 6 generations [20].
BM transplantations were carried out by tail vein injection of
whole CD45.2 BM cells into CD45.1 recipients, which had been
subjected to a lethal dose (900 rad) of gamma-irradiation 16 hours
prior to transplantation. In the non-competitive setup, 1 to 2
million donor cells were used. In the competitive setup, primary
transplantations were carried out by co-injecting 500.000 donor
cells and 500.000 competitor cells (CD45.1). For secondary
transplantations, BM cells from 6–7 primary recipients from the
competitive transplantations were pooled, and 5 million of these
cells were used for as secondary donor cells.
Flow cytometry
C/EBPa-ER and C/EBPa-S248A-ER expressing cell lines
were stained with Mac-1 and Gr-1 and analyzed on a
FACSCalibur. Briefly, 500.000 cells were incubated with 1 mlF c
receptor block (anti-CD16/32, BD) in 20 ml PBS3%FCS on ice for
15 min. The cells were washed with cold PBS3%FCS and stained
in the dark on ice with antibodies against Mac-1 and Gr-1 or
corresponding isotype controls (eBioscience) for 20 min. Cells
were resuspended in PBS3%FCS and run on a FACSCalibur
(BD).
The hematopoietic compartment was analyzed as follows:
Femurs and tibiaes were collected and crushed in PBS+3% FCS.
The BM cells were stained for mature cells using antibodies
against Ter119, CD71, Mac-1, Gr-1, B220, CD4, and CD8a
(eBioscience) and stem and progenitor cells using antibodies
against Lineage (CD3e, B220, Mac-1, Gr-1), Sca-1, c-Kit, CD105,
CD41, FcgRII/III, Ter119 (eBioscience) and CD150 (Biolegend).
For the analysis of transplanted animals, antibody cocktails were
supplemented with CD45.1 and CD45.2 antibodies (eBioscience).
After wash the mature stained cells were resuspended in PBS+3%
FCS containing DAPI (0,2 mg/ml, Invitrogen) and cells stained for
stem and progenitor cells were resuspended in PBS+3% FCS
containing 7AAD (1 mg/ml, Invitrogen). The samples were run on
a LSRII and analyzed using FlowJo software.
Cytospins, colony assays and serial replating experiments
For the analysis of colony-forming potential, BM cells (5,000–
20,000 cells/35-mm dish) were seeded in methylcellulose-based
medium (M3434, StemCell Technologies Inc.) supplied with
erythropoietin, IL-3, IL-6, and stem cell factor. After 10–12 d in
culture, the colonies were scored as CFU-GM, BFU-E, or CFU-
GEMM. In the serial replating experiments, a similar number of
BM cells were seeded in M3434 medium, cultured for 7 days, and
the number of colonies was counted. The cells were harvested,
washed with PBS, diluted and replated in fresh M3434 medium
and cultured for an additional 7 d. This procedure was repeated
for 5 weeks.
Preparation of cytospins was performed as described in [21].
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Figure S1 Liver, lung and spleen tissue sections. Tissue
sections from Cebpa
+/+ and Cebpa
S248A/S248A mice were stained
with a Hematoxylin/Eosin solution. There were no changes in
morphology of the tissues.
(TIF)
Figure S2 Expanded stem and progenitor compartment
in a fraction of the one-year old Cebpa
S248A/S248A mice.
(A) Seven out of 23 Cebpa
S248A/S248A mice had a skewed lineage
distribution with a decreased GMP/preMegE ratio compared to
Cebpa
KI/KI. Black line indicates cut-off. Cut-off was defined as
mean of Cebpa
KI/KI2standard deviation. Asterisks show the mice
analyzed in figure 4B and 4C. (B) Seven out of 23 Cebpa
S248A/S248A
mice had an expanded LSK compartment compared to Cebpa
KI/
KI. Black line indicates cut-off. Cut-off was defined as mean of
Cebpa
KI/KI+standard deviation. Asterisks show the mice analyzed
in figure 4B and 4C. (C) Partial overlap of mice with expanded
LSK compartment and low GMP/preMegE ratio. (D) Enlarged
spleen from a one-year old Cebpa
S248A/S248A mouse.
(TIF)
Figure S3 Correlation of mice with enlarged spleen,
enhanced LSK compartment and myeloid-biased differ-
entiation in 18–24 months old Cebpa
S248A/S248A mice. (A)
Six out of 21 Cebpa
S248A/S248A mice had a skewed lineage
distribution with a decreased GMP/preMegE ratio compared to
Cebpa
KI/KI. Black line indicates cut-off. Cut-off was defined as
mean of Cebpa
KI/KI2standard deviation. (B) Six out of 21
Cebpa
S248A/S248A mice had an expanded LSK compartment
compared to 1 out of 8 Cebpa
KI/KI. Black line indicates cut-off.
Cut-off was defined as mean of Cebpa
KI/KI+standard deviation. (C)
Six out of 21 Cebpa
S248A/S248A mice had an enlarged spleen
compared to Cebpa
KI/KI. (D, E, F) Quantification of the data from
(A, B, C). Cebpa
S248A/S248A mice displaying a GMP/preMegE
ratio,mean of Cebpa
KI/KI2standard deviation (n=6) were
termed ‘‘progressed’’. Numbers of mice in the other groups were
as follows: Cebpa
KI/KI (n=8) and Cebpa
S248A/S248A (n=15) mice.
Triangle designates enhanced LSK compartment, white color
designates enlarged spleen, ns=not significant (mean +/2
standard deviation). (G) Correlation plot of mice with enlarged
spleen, expanded LSK compartment and low GMP/preMegE
ratio.
(TIF)
Figure S4 Erythroid-biased differentiation of pro-
gressed Cebpa
S248A/S248A mice. (A) Progressed Cebpa
S248A/
S248A mice (n=6) had increased level of erythroid cells in the BM
and (B) displayed enhanced BFU-E colony formation. Numbers of
mice in the other groups were as follows: Cebpa
KI/KI (n=15) and
Cebpa
S248A/S248A (n=8) mice. Triangle designates enhanced LSK
compartment, white colour designates enlarged spleen, P values
designate significance between progressed Cebpa
S248A/S248A and
Cebpa
KI/KI, ns=not significant (mean +/2 standard deviation).
(TIF)
Figure S5 Expanded stem and progenitor compartment
in some of the recipients recieving Cebpa
S248A/S248A BM.
(A) Four out of seven recipients of Cebpa
S248A/S248A BM had a
decreased GMP/preMegE ratio compared to Cebpa
KI/KI. Black
line indicates cut-off. Cut-off was defined as mean of Cebpa
KI/
KI2standard deviation (B) Four out of seven recipient mice with
BM from Cebpa
S248A/S248A had an expanded LSK compartment.
Black line indicates cut-off. Cut-off was defined as mean of
Cebpa
KI/KI+standard deviation. (C) Partial overlap of mice with
expanded LSK compartment and low GMP/preMegE ratio.
(TIF)
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